Remus Pharmaceuticals Limited reported its financial results for the year ending March 31, 2025, showing a significant revenue increase to INR 620.36 Cr from INR 212.94 Cr in FY24, with a year-on-year growth of 191.33%. The company also highlighted business expansions in Saudi Arabia and several other nations.